Novavax, Inc. (NVAX)
NASDAQ: NVAX · IEX Real-Time Price · USD
-1.39 (-9.65%)
At close: May 17, 2024, 4:00 PM
+0.39 (3.00%)
Pre-market: May 20, 2024, 4:26 AM EDT

Novavax Revenue

Novavax had revenue of $996.61M in the twelve months ending March 31, 2024, down -26.66% year-over-year. Revenue in the quarter ending March 31, 2024 was $93.86M with 15.94% year-over-year growth. In the year 2023, Novavax had annual revenue of $983.71M, a decrease of -50.36%.

Revenue (ttm)
Revenue Growth
P/S Ratio
Revenue / Employee
Market Cap
1.83B USD

Revenue Chart


Fiscal Year End Revenue Change Growth
Dec 31, 2023983.71M-998.17M-50.36%
Dec 31, 20221.98B835.58M72.89%
Dec 31, 20211.15B670.69M141.02%
Dec 31, 2020475.60M456.94M2,448.48%
Dec 31, 201918.66M-15.63M-45.57%
Dec 31, 201834.29M3.11M9.98%
Dec 31, 201731.18M15.82M103.06%
Dec 31, 201615.35M-20.90M-57.65%
Dec 31, 201536.25M5.59M18.24%
Dec 31, 201430.66M9.74M46.59%
Dec 31, 201320.92M-1.16M-5.26%
Dec 31, 201222.08M7.39M50.30%
Dec 31, 201114.69M14.35M4,182.22%
Dec 31, 2010343.00K18.00K5.54%
Dec 31, 2009325.00K-739.00K-69.45%
Dec 31, 20081.06M-449.00K-29.68%
Dec 31, 20071.51M-225.00K-12.95%
Dec 31, 20061.74M-3.61M-67.47%
Dec 31, 20055.34M-2.92M-35.31%
Dec 31, 20048.26M-3.53M-29.91%
Dec 31, 200311.79M-3.22M-21.46%
Dec 31, 200215.01M-9.06M-37.65%
Dec 31, 200124.07M21.59M872.36%
Dec 31, 20002.48M1.29M109.57%
Dec 31, 19991.18M500.00K73.42%
Dec 31, 1998681.00K161.00K30.96%
Dec 31, 1997520.00K464.00K828.57%
Dec 31, 199656.00K-212.00K-79.10%
Dec 31, 1995268.00K-416.88K-60.87%
Dec 31, 1994684.88K--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Addus HomeCare 1.09B
NeoGenomics 610.66M
Protagonist Therapeutics 314.95M
Zai Lab 291.07M
Ardelyx 159.11M
Fusion Pharmaceuticals 2.04M
Inhibrx 1.78M
Keros Therapeutics 234.00K
Revenue Rankings